Skip to main content

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Papel de los productos finales de glicación avanzada (AGEs) en el daño por isquemia-reperfusión del corazón senescente

IP: Marisol Ruiz Meana
Collaborators: Imanol Otaegui Irurueta, Elisabet Miro Casas
Funding agency: Instituto de Salud Carlos III
Funding: 92565
Reference: PI15/01655
Duration: 01/01/2016 - 30/06/2019

Patologia Cardiocirculatòria (GRC)

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Artur Evangelista Masip, Elsa Nieto Santa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Aida Ribera Sole, Santiago Aguade Bruix, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Laura Dos Subirá
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 1572
Duration: 01/01/2014 - 31/12/2016

Papel de los microdominios celulares en el deterioro de la función cardíaca durante el envejecimineto y su menor tolerancia al estrés

IP: Marisol Ruiz Meana
Collaborators: Elisabet Miro Casas
Funding agency: Instituto de Salud Carlos III
Funding: 210540
Reference: PI12/00788
Duration: 01/01/2013 - 31/07/2016

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Artur Evangelista Masip, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Estevo Santamarina Pérez

Estevo Santamarina Pérez

Head of group
Research Group on Status Epilepticus and Acute Seizures
Read more
Rocío Piñera Moreno

Rocío Piñera Moreno

Research assistant
Gene and Cell Therapy
Read more
Joana Margalida Cladera  Sastre

Joana Margalida Cladera Sastre

Research technician
Neurodegenerative Diseases
Read more
Kushal Mukesh Lakhani Mahtani

Kushal Mukesh Lakhani Mahtani

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.